In October 2010 funding for the Irish Council for Bioethics (ICB) ceased. The decision to close down this body came as a result of the severe financial pressure that Ireland found, and still finds, itself under. It is broadly acknowledged that these fiscal difficulties arose partly through international events but also through domestic political ineptitude, corporate greed, and an abysmal failure of governance. In a belated and enforced attempt at fiscal rectitude, the Special Group on Public Service Numbers and Expenditure was established, and it recommended a wide variety of cost-saving measures entailing rationalization, reorganization, consolidation, and prioritization, including “the discontinuation of funding for the Irish Council for Bioethics.”Footnote 1 In its final report, the council summed up its dismay at the decision:
It is the worst of times to make this decision. It is a decision that has all the hallmarks of an expediency that is rash rather than reflective, damaging rather than deliberative. While significant funding has been allocated to science and technology research during the last decade, with the exception of the establishment of the ICB, similar investments have not been made in the area of research governance. Having made the important and well informed decision of establishing the ICB and having taken a lead in the area, the decision to disband the ICB is a retrograde step, especially in a time when many other international jurisdictions have established such bodies and continue to do so.Footnote 2
The purpose of this review is to outline the original reasons for establishing the ICB and its subsequent functioning, and to evaluate whether the austerity measures introduced by the government justified its closure.
Establishing the Irish Council for Bioethics
In 1999, a working party (largely made up of civil servants) was convened with the specific remit of examining issues pertaining to genetically modified organisms, but also with broader terms of reference allowing its members to look at how ethical difficulties arising from biotechnological advances might best be dealt with. This interdepartmental working party identified that biotechnology has “direct and far-reaching” consequences, with the potential for benefit or harm “in areas as central to human concerns as food supply, the plight of the poor in developing countries, healthcare, and the environment.”Footnote 3 It also acknowledged that further technological advances “will directly give rise to more difficult and complex ethical questions.” The members noted that, at that time, a number of countries had established committees on bioethics and thus advised that it was “now time in our view to establish a forum in this country to consider the ethical issues raised by biotechnology in an informed, dispassionate and independent way. We recommend that a national biotechnology ethics committee should be established for these purposes.”Footnote 4
It was proposed that the Royal Irish Academy (an autonomous, generally respected body of scholars in both the sciences and the humanities) should be invited to consider how best to establish and operate such a committee, the academy having recently convened a conference on ethics and the molecular life sciences. The interdepartmental group suggested that the role of any proposed forum would be to clarify the ethical issues that arise out of biotechnology, formulate these concerns in moral terms, and communicate them to decisionmakers, scientists, and the general public. Although they envisaged that “the Government would be entitled to refer questions to such a body for consideration from time to time, the proposed committee should be fully independent in its operations. Its terms of reference should be broad and flexible.”Footnote 5
The Irish Council for Bioethics (Comhairle Bitheitice na hÉireann) was subsequently established in 2002 by the Royal Irish Academy as an independent, autonomous, nonstatutory body charged with considering the ethical issues raised by developments in science and medicine. The council was formally inaugurated by the minister for enterprise, trade and employment in January 2003 and was financed through Forfás (Ireland’s national policy and advisory board for enterprise, trade, science, technology, and innovation), itself a state-funded enterprise. The terms of reference of the ICB were as follows:
1) To identify and interpret the ethical questions raised by biological and medical research in order to respond to and anticipate questions of substantive concern.
2) To investigate and report on such questions in the interests of promoting public understanding, informed discussion, and education.
3) In the light of the outcome of its work, to stimulate discussion through conferences, workshops, lectures, and published reports and, where appropriate, to suggest guidelines.Footnote 6
The first council, which sat for a three-year term, was made up of 21 members (not all of whom completed the full term). The membership consisted of three lawyers, two theologians, one philosopher, and a variety of physicians, scientists, and journalists. Members were invited to join the council “by virtue of their personal expertise, distinction and authority” rather than as representatives of particular bodies or professions.Footnote 7
How the Irish Council for Bioethics Functioned
In selecting a work program for its first term of office, individual council members were invited to propose for consideration issues that they felt should be addressed. In addition, the government and professional bodies were entitled to refer questions and issues to the council for consideration. The issues ultimately chosen for scrutiny were selected on the basis of “public interest and concern, relevance to Ireland and in particular whether the Council could make a unique contribution to the discussion of an issue.”Footnote 8 The first council established three working groups to address matters arising with regard to (1) research ethics committees, (2) human biological material, and (3) genetically modified organisms. Each of the working groups was composed of a combination of council members and external individuals who were co-opted for their expertise in the relevant issue. The composition of the working groups aimed to ensure that an informed and balanced discussion of each issue took place, through the representation of a broad range of disciplines and views. Three documents were subsequently published: a guidance document for research ethics committees (2004);Footnote 9 a report on human biological material (2005)Footnote 10 containing 23 recommendations relating to the collection, use, storage, and disposal of biological material in the context of research; and an opinion document assessing the positive and negative potential of genetically modified crops and food (2005).Footnote 11 As public interaction was deemed a cornerstone of the ICB’s remit, these reports were informed not only by co-opted experts but also by public consultation. In the case of the opinion on genetically modified food, the council received 560 submissions.Footnote 12
Over the next five years the subsequent two councils produced four further reports. These related to advance directives,Footnote 13 stem cell research,Footnote 14 biometrics,Footnote 15 and research integrity.Footnote 16 There were also a series of information packs produced on a variety of subjects, including euthanasia, forensic DNA databases, environmental ethics, organ donation, and human enhancement. These emerged from the Bioethics Radio Series, broadcast nationally with the title The Big Science Debate: Exploring the Ethical Issues. This level of output would seem to have been broadly in keeping with similar bodies in other countries; the Nuffield Council, for example, published 18 reports and discussion papers over a period of 18 years.Footnote 17 Although no standard of productivity is mentioned in the setting up of the council, the generation of a substantial body of work would seem to have allowed the ICB to fulfill adequately its mandate—the identification of ethical questions raised by biological and medical research; the investigation of and reporting on such questions; and the stimulation of discussion and the publication of reports, suggesting guidelines where appropriate.
The Stem Cell Debate
Perhaps unsurprisingly, the ICB’s document on stem cell research proved its most controversial piece of work. Ireland’s legal system is based on English common law but is subject to a written constitution (Bunreacht na hÉireann, enacted in 1937). All legislation must be in keeping with the Constitution, and any change to this document requires a public plebiscite. The legal and philosophical basis of Bunreacht na hÉireann is the natural law theory of Thomas Aquinas, and until recently the laws of the Irish state in the areas of marriage, contraception, abortion, and homosexuality reflected those of the Catholic Church.Footnote 18 Article 40.3.3 of the Constitution guarantees the right to life of the “unborn,” and thus the legal status of stem cell research is uncertain.Footnote 19 Standard Catholic teaching holds that life begins at conception, and that stem cell research using human embryos is immoral. However, there is no legislation in Ireland governing human embryonic stem cell research (nor does it have a legislative framework to deal with artificial human reproduction).
In light of this legal lacuna, and mindful of the debate prompted by European Union funding of embryonic stem cell research, the ICB appointed a rapporteur group to consider the scientific, ethical, and legal questions raised by such research. Among the key opinions put forth in the resulting document, Ethical, Scientific and Legal Issues Concerning Stem Cell Research, were the following:
1) The embryo has significant moral value rather than full moral status.
2) The moral value of human in vitro fertilization (IVF) embryos that will otherwise remain frozen or be destroyed (known as supernumerary IVF embryos) needs to be balanced against the moral value of those members of society who are suffering from debilitating illnesses.
3) Because of our obligation to care for humankind, embryonic stem cell research is acceptable in certain contexts. The council expressed support for people’s decisions to donate their supernumerary embryos.
4) The creation of embryos specifically for research was regarded as currently unjustified, although this may change with the advancement of science, when again the balance of the ethical concern over the creation of embryos versus the value to society of such research may have to be reevaluated.
5) It was the view of the council that a failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and its application undermines the moral value of the human embryo and may hinder the development of this field of research in Ireland. Thus, the council recommended the establishment of an appropriate regulatory authority.
These opinions are particularly interesting in light of the public engagement that took place in the lead-up to the publication of the document. The council professed itself to be mindful of the diversity of ethical views held by individuals and members of the various communities living in Ireland. Thus, the rapporteurs met with stakeholders with an academic, theological, or scientific interest in the issue, and also with patient advocacy groups.
The public was invited to express its views on stem cell research through an online or postal questionnaire. Almost 2,200 individuals responded to the public consultation. Three-quarters of respondents had a third-level education, and 72 percent felt that they had a significant degree of knowledge of stem cell research. Of the individual respondents, 69 percent believed an embryo acquires full moral status at fertilization, and less than 4 percent held that this was acquired after birth. Just more than 70 percent thought it was not acceptable to use embryos produced (but not used) during IVF treatment for stem cell research in Ireland, and a similar number felt it unacceptable to import embryonic stem cell lines into Ireland for this purpose. The rejection rate for the production of cloned embryos or cloned human-animal hybrid embryos as a source of embryonic stem cells was approximately 80 percent. Only 27.8 percent of respondents claimed that they would be willing to use medical treatments that were developed using embryonic stem cells.Footnote 20 These figures probably do not reflect the opinions of the population at large; prior work commissioned by the ICB identified the relevant data as follows:
1) 57 percent of Irish adults believe that life begins at conception.
2) 44 percent believe that embryos produced but not used during IVF treatment should be used in medical research.
3) More than one-third of Irish adults believe that scientists should be allowed to create embryos specifically for research.
4) 54 percent said they would use new treatments for diseases developed using embryonic stem cell research.Footnote 21
As with most voluntary questionnaires, the participant population responding to the call for submissions on stem cell research was most likely biased toward those with a particular interest in the matter. However, given that the opinions voiced by the majority of respondents would seem to be in direct opposition with the conclusions of the council, this leaves the utility and validity of seeking the views of members of the public in doubt. In particular, the gradualist approach to the moral status of the embryo taken by the council is considerably at odds with the Catholic position held by a majority of the population. This is not to state that the position of the ICB lacks legitimacy, but rather that it does not represent a majoritarian perspective. It would seem that the members of the ICB had more liberal attitudes toward science in general, or perhaps stem cell research in particular, than many Irish citizens. This raises questions as to how members of the council are chosen, whether they should be selected to represent (at least) prominent constituencies from within the populace, and what role such bodies should have within a democratic state. With the global growth of national bioethics councils, enthusiastically endorsed and facilitated by UNESCO,Footnote 22 these questions are of importance not just to Ireland. There is no scope within this article to address these matters, which, in any case, have been discussed elsewhere.Footnote 23 However, on a narrow national view, the ICB balanced the status of the embryo against the needs of sick populations and came down in favor of the latter. It is uncertain how much, or if at all, the opinions of members of the public swayed the views of the council, whether the public consultation process was simply a matter of optics, or whether the recommendations of the council might have been more permissive in the absence of the strident voices of “pro-life” activists.
Notably, the final report appears to be a consensus document; there is no evidence, either in the text or in the media reports around its release, of any dissenting voices. That no member of the council would disagree with any aspect of a report that was likely to be divisive within Irish society might suggest that robust debate did not occur within the ICB, perhaps because its members were from similar ideological backgrounds. As one commentator observed, “in ethics, blanket consensus is rarely welcome, given the complexities of the issues, knowledge and viewpoints.”Footnote 24 If all members held the same view, then this, perhaps, might mean that the conflicting opinions of those external to the council might not have been given due consideration. On the other hand, if there were alternative positions articulated within the ICB, then, given the importance of dialogue and the dissemination of ideas in the terms of reference, it would seem relevant that these be included within the document. One example of such discursive practice comes from the Danish Council of Ethics. In their discussion document on the moral status of the embryo, they identified four points of view that were illustrative of the differing views held by the Council of Ethics’s members.Footnote 25 Additionally, the Danish Council’s position paper on microinsemination and preimplantation genetic diagnosis outlined the ethical reservations of eight members and then set out the arguments that another nine members regarded as outweighing those doubts. Dodds and Thompson have suggested that the Danish Council thus laid out the multiple positions supported or supportable; it being neither required nor intended that public or expert consensus on the issue be represented.Footnote 26
The ICB report was not without impact. There was the predictable outcry from social conservatives. In a debate, one member of the Seanad (Senate) lamented the composition of the council:
I wish to raise a question about the Irish Council for Bioethics. . . . Recently, by a margin of 13 to nil, its board came to a decision that affects life. Approximately 60% of the country holds pro-life views, yet 13 people on a committee, unanimously, made a decision that affects life. State funding is going to this organisation and the Commission on Assisted Human Reproduction. Out of the 38 members of each body’s board, only one spoke out for pro-life values.Footnote 27
Another politician was similarly unhappy: “It is essential that people of independent opinions be appointed to such bodies. If people with predispositions are appointed, the outcomes on which Government policy are based are predetermined and inevitable.”Footnote 28 It is possible that the politician in question might have been less distraught had the “predispositions” been more “pro-life.”
The report was used with some effect by proponents of stem cell research. As stated earlier, Ireland has no legislation either permitting or prohibiting human embryonic stem cell research. In the absence of regulation, some academic institutions that had been involved in stem cell research decided to regulate themselves. The governing body of University College Cork (UCC) debated the issue in November 2008 and recommended, by a very slim majority (16 to 15), to allow human embryonic stem cell research to take place at the institution under strict, self-imposed guidelines to be drawn up by the University Research Ethics Board. The university stated that it had taken the ICB opinion into consideration when drawing up its guidelines.Footnote 29
Closure
In light of the financial crisis, all government departments were required to make cuts in their budgets. The Department of Enterprise, Trade and Employment proposed a saving of €0.4 million through discontinuing the funding of the ICB, and this was accepted by the aforementioned special group. In fact, the nominal budget allocation for 2010 was €270,000, of which €232,540 was allocated. This covered the salary of the managing director, the research officer, and the communications and outreach officer, as well as the office-running costs and the work of the council.Footnote 30 The Irish government proposes to save 7.5 billion euros between 2011 and 2014. The cumulative savings that would accrue over this period through the closure the ICB (assuming an unchanged level of funding) would be approximately 0.00013 percent of the required total saving. The actual figure will be even less, because the three salaried members of the secretariat were assimilated into the Department of Health, and so their salaries and pension contributions must be discounted. The economic argument for closing down the ICB seems unconvincing at best, but, despite the paltry contribution sacrificing the ICB will make to the nation’s finances, in difficult times quangos (quasi-autonomous nongovernmental organizations) are frequently targeted as unnecessary expenditure.
Although the closure of the ICB was met with disappointment on the part of its members, and some commentators, there was no outpouring of public resentment, nor any objection from the opposition benches in the Dáil (Parliament). There are possibly several reasons for this. First, despite the public discussion around the ICB reports (and in particular the one dealing with stem cell research), the term “bioethics” remains esoteric and unfamiliar to many people. The ICB’s commissioned report identified that 77 percent of Irish adults either had never heard of the term “bioethics” or, if they had heard of it, they knew nothing about it.Footnote 31 Second, as has been pointed out, there are plenty of contenders for cruelest cut and most pointless expediency in the race to save money.Footnote 32 Closure of the ICB is unlikely to have the public impact that might be caused by widespread job losses, cuts in health and welfare spending, or a reduction in teachers for children with special needs. It is thus an easy target. Third, it has been suggested that “many politicians do not see the merit in initiating or supporting any sort of bioethics-related regulation, for fear that it may harm their electability.”Footnote 33 Politically, it might be argued, there may be few votes to be gained in Ireland by supporting, say, legislation on embryonic stem cell research, and potentially many more to be lost. In addition, the ICB, by publicly calling for regulation of stem cell research, was unlikely to have made many friends among politicians who had witnessed the bitter debates that surrounded the abortion referenda of the 1980s and 1990s, and who would be wary of revisiting any issues touching on the status of the embryo.Footnote 34
However, more recent events have added to the pressure on the government to legislate on this area. The Roche case determined the fate of three frozen embryos at the center of a dispute between a separated couple.Footnote 35 The Supreme Court unanimously ruled that the frozen embryos were not the “unborn” within the meaning of Article 40.3.3 and thus were not entitled to constitutional protection. Gough has argued that, as a consequence of this judgment, there is no legal foundation to prohibit assisted human reproduction, embryonic stem cell research, or other related therapeutic applications, such as pre-implantation diagnosis, from taking place in Ireland.Footnote 36 The justices of the Supreme Court were scathing in their criticism of the serial abdication of legislative responsibility by successive Irish governments in this domain. A subsequent case in the European Court of Human Rights also pointed to legislative failure in the provision of abortion services that were not unlawful under the Constitution.Footnote 37 Abortion is currently permissible when there is a risk to the life of a pregnant woman, rather than simply to her health or well-being. Despite wishing to access what should be a legal service, such women must travel to other countries in order to procure a termination of pregnancy. McGuinness suggests that the judgment in the A,B,C case “pushes the Irish government to provide guidance on those abortions that are already legal.”Footnote 38 However, legislation or regulation pertaining to the embryo or fetus does not appear imminent.
Conclusion
Yuko asked why Ireland, a state with a strong legal and human rights tradition, falls behind other countries in relation to handling ethical issues. She suggests that an explanation might encompass the dominance of the Catholic Church, a lack of political will, a lack of scientific debate, and the paucity of bioethics education in Ireland.Footnote 39 Yet, some of the most fundamental issues of interest to bioethics—how we are born, live, and die—have been societal concerns for millennia. What biotechnological advances have done, and will continue to do, is alter and complicate these matters and render comprehension and decisionmaking increasingly difficult. As scientific innovation accelerates, the potential also increases for conflict between individuals who regard any “advances” in differing lights. Policymaking, even in the absence of the abdication of political responsibility, becomes progressively more difficult in such an environment, especially if areas of controversy arise out of a failure to effectively debate the relevant issues.
Ireland is seeking to drive its economy forward through the fostering of a “knowledge economy.” The state body, Science Foundation Ireland (SFI), proposes that the “key to developing sustainable long-term economic growth in Ireland is to focus on sectors where real potential exists, especially in the field of R&D and innovation.”Footnote 40 SFI stresses the importance of convincing potential investors that Ireland’s “human resource capital and knowledge-base” will provide a “competitive advantage for firms which invest in Ireland.”Footnote 41 The closure of the ICB and the absence of any legislation on the research uses of human tissue (a bill has been proposed but not passed) seem to leave biomedical science in Ireland largely unregulated and unexamined. In its final report, the ICB observed that
a smart economy cannot be achieved without a society built on strong ethics and values. A national discussion about what should and should not be permissible when it comes to making babies, ameliorating disease or growing our food requires a common language and honest brokers to guide the discussion and keep it fair and factual. The ICB has consistently sought to enhance knowledge and inform debate around these issues by challenging itself and others to examine all facets of the bioethical challenges, which face us. The task of well-informed and carefully-reasoned bioethics is to guide policymakers. This role has become ever more pertinent as much of the legislation in Ireland concerning the regulation of biotechnology and biomedicine emanates from the European Commission and Council of Ministers.Footnote 42
Ethical issues arising from medicine and science are matters of concern for all citizens in a society. Some may be uninterested in any emerging quandaries, but individuals should have the opportunity to develop an informed opinion and express it. It seems probable that the number of such issues is likely to increase in the coming years, as the scientific juggernaut accelerates. Some institution that originates and facilitates debate, provides expert opinion, and informs both public and policymakers would seem helpful in the deliberative process. The reasons for setting up the ICB remain valid today, and its absence leaves Ireland as the sole country in the EU without an effective bioethics organization.Footnote 43
